Sign in Pull a receipt

RDY

DR REDDYS LABORATORIES LTD

Healthcare · Drug Manufacturers - Specialty & Generic

$80.56 sample

+1.15 (+1.45%) 1D

Market cap

$185.9B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-08

Alerts

8

Price$80.56 +25.80% 3M daily closessample

80.8562.96

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 23INSInsider sell: Director
Oct 20INSInsider sell: 10% owner
Oct 15INSInsider buy: Director
Oct 08SECDEF 14A filed
Sep 30SECForm 144 filed
Sep 25INSInsider buy: General Counsel
Sep 17INSInsider sell: Chief Executive Officer
Sep 11INSInsider sell: Chief Financial Officer

Sign up to see the real RDY record →

Company facts

SEC EDGAR registration

Name: DR REDDYS LABORATORIES LTD
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Smart-money score: +34sample, -100 to +100
Reporting currency: USD

Who is positioning in RDY

sample

Insiders: 7 insider transactions over 90 days, net selling, $82.1M
Congress: No member trades over 90 days
Institutions · 13F: 27 funds hold $2.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$11.6B +12.3% y/y

Q4 2024Q3 2026

Inventory$7.1B +9.8% y/y

Q4 2024Q3 2026

Accounts receivable$5.1B +10.8% y/y

Q4 2024Q3 2026

Total debt$13.5B +13.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $36.0B -13.5% 3M
Sample peer B: $163.2B +6.4% 3M
Sample peer C: $56.1B +8.0% 3M
Sample peer D: $52.7B +0.2% 3M
Sample peer E: $27.0B -1.6% 3M